Does saffron help anxiety when added to sertraline?
Yes, modestly. In a 6-week trial, patients taking saffron alongside sertraline ended with a lower anxiety score than those taking sertraline plus placebo: a mean HAM-A of 2.95 versus 5.05. The double-blind randomized controlled trial enrolled 40 adults with mild-to-moderate generalized anxiety disorder, and both groups improved substantially, with the saffron group improving somewhat more.
The trial’s rationale is that saffron’s two major components, safranal and crocin, block the reuptake of serotonin, norepinephrine, and dopamine, which overlaps with and extends sertraline’s mechanism.
What the data show:
- Effectiveness: HAM-A scores fell by 17.25 points with saffron versus 15.35 points with placebo, both on top of sertraline (p = 0.029)
- End-of-trial scores: 2.95 with saffron versus 5.05 with placebo at week 6 (p = 0.005)
- Study scope: Double-blind randomized trial of 40 patients (20 saffron, 20 placebo) over 6 weeks
- Tolerability: Side effects were tolerable, and none led to stopping the supplement
The trial, published in Archives of Neuroscience, is the first human test of saffron as an add-on to standard drug therapy in generalized anxiety disorder, and its authors call for larger and longer trials before the effect can be considered confirmed.
Dr. Kumar’s Take
I like the logic of this study. Sertraline blocks serotonin reuptake, and saffron’s active compounds, crocin and safranal, act on serotonin, norepinephrine, and dopamine reuptake, so pairing them is pharmacologically coherent rather than wishful. What I want people to see clearly is the size of the effect. Both groups improved a lot, because both groups were on sertraline. The saffron group improved a little more: about two points further down the Hamilton scale, and about two points lower at the end. That is a real, statistically significant difference in 40 patients, and it is also a small one. This is a promising signal in a single small trial from one clinic, not grounds for changing how I would treat anxiety today. I would want a larger sample and a longer follow-up before I put weight on it.
Study Snapshot
This double-blind, randomized controlled trial tested saffron as an add-on therapy to sertraline in patients with mild to moderate generalized anxiety disorder diagnosed by DSM-V criteria. Patients aged 18 to 55 who were referred to a private psychiatric clinic were randomly assigned to sertraline plus saffron or sertraline plus placebo for 6 weeks, with the 14-item Hamilton Anxiety Rating Scale (HAM-A) recorded at baseline, week 3, and week 6. Diet was tracked with 3-day food recalls at each visit so that nutrient intake could be accounted for, and the analysis adjusted for age, baseline energy intake, baseline HAM-A score, and weight change.
Results in Real Numbers
The trial enrolled 40 patients with mild-to-moderate generalized anxiety disorder (HAM-A scores of 18 to 24), with 20 patients assigned to saffron plus sertraline and 20 patients to placebo plus sertraline. Mean age was 29.65 years (SD 8.45) in the saffron group and 32.40 years (SD 6.74) in the placebo group, with 13 women (65%) and 7 men in each group. All participants took 50 mg sertraline daily. The saffron group also took a 500 mg capsule containing 450 mg of saffron each day for 6 weeks; the placebo group took a 500 mg starch capsule on the same schedule.
Anxiety scores fell significantly within both groups. In the adjusted analysis, the reduction in total HAM-A score from baseline was 17.25 points (SD 2.67) with saffron versus 15.35 points (SD 2.30) with placebo, a difference that reached statistical significance (p = 0.029). At the end of week 6, the saffron group’s mean HAM-A score was 2.95 versus 5.05 in the placebo group (p = 0.005). The benefit of saffron here is the increment on top of sertraline, not the bulk of the improvement, which both groups shared.
Side effects were tolerable and did not lead any patient to stop taking the supplement.
Who Benefits Most
The patients studied were adults aged 18 to 55 with mild to moderate generalized anxiety disorder, scoring 18 to 24 on the HAM-A, who were starting sertraline at 50 mg daily. That is the group these results speak to, and only over a 6-week window.
People interested in integrative approaches, where a standardized natural compound is added to conventional treatment under medical supervision rather than substituted for it, are the ones this design was built for. Saffron was tested as an addition to sertraline, never as a replacement.
Safety, Limits, and Caveats
The combination was tolerated in this trial, but saffron can interact with other medications, and any supplement added to an SSRI belongs in a conversation with the prescriber. The trial covered mild to moderate anxiety only, so the results say nothing about severe anxiety or other psychiatric conditions.
The main limits are size and duration. Forty patients at a single clinic, followed for 6 weeks, is enough to detect a difference but not enough to settle one. The authors themselves conclude that larger trials with longer follow-up are needed to confirm the effect. Quality and authenticity of saffron products also vary, which matters when a trial result rests on a specific 450 mg daily dose.
Practical Takeaways
- Treat this as one small, short trial, not as established practice
- If you are considering saffron alongside an SSRI, raise it with the prescribing clinician first, because of interaction potential
- The tested regimen was 450 mg of saffron daily for 6 weeks, added to 50 mg of sertraline daily
- Expect an incremental effect at best: most of the improvement in this trial came from sertraline, which both groups received
- Saffron was studied as an addition to drug treatment, not as a substitute for it
What This Means for Anxiety Treatment
Roughly half of patients with generalized anxiety disorder do not get the expected result from first-line drug therapy, and side effects hurt adherence, which is the gap add-on strategies are meant to fill. This trial is the first human test of saffron in that role for generalized anxiety disorder, and it produced a small positive signal.
Where it leads next depends on replication. A two-point difference on the Hamilton scale in 40 patients over 6 weeks is a reason to run a larger trial, not a reason to conclude the question is settled.
Related Studies and Research
Episode 31: Depression Explained, The Biology Behind the Darkness
Episode 32: Depression Recovery Roadmap: A Step-by-Step, Evidence-Based Plan
FAQs
Is it safe to combine saffron with sertraline?
In this 6-week trial the side effects were tolerable and no patient stopped the supplement because of them. That is a small sample over a short period, so consult the prescribing clinician before combining any supplement with an SSRI.
What dose was used in the trial?
A 500 mg capsule containing 450 mg of saffron, taken once daily for 6 weeks, alongside 50 mg of sertraline daily.
How much better was the saffron group?
HAM-A scores fell by 17.25 points with saffron versus 15.35 points with placebo, and the final scores were 2.95 versus 5.05. Both groups improved significantly; saffron added an increment on top of that.
Bottom Line
Adding saffron to sertraline produced a small but statistically significant extra reduction in anxiety symptoms over 6 weeks in 40 patients with mild to moderate generalized anxiety disorder. It is a promising early result from a single small trial, and the authors are right that larger, longer studies are needed before it changes practice.
